Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

720 ARTÍCULOS , VIENDO DEL 121 AL 135

The efficacy and safety of lecanemab 10 mg/kg biweekly compared to a placebo in patients with Alzheimer's disease: a systematic review and meta-analysis of randomized controlled trials

Abdelazim K, Allam AA, Afifi B, Abdulazeem H, Elbehiry AI.

Neurol Sci. 2024 Aug;45(8):3583-3597. doi: 10.1007/s10072-024-07477-w. Epub 2024 Apr 3.

Effects of Exercise Training on Immune-Related Genes and Pathways in the Cortex of Animal Models of Alzheimer's Disease: A Systematic Review

Widjaya MA, Lee SD, Cheng WC, Wu BT.

J Alzheimers Dis. 2024;98(4):1219-1234. doi: 10.3233/JAD-230803.

Alkaloids as drug leads in Alzheimer's treatment: Mechanistic and therapeutic insights

Rezaul Islam M, Akash S, Murshedul Islam M, Sarkar N, Kumer A, Chakraborty S, Dhama K, Ahmed Al-Shaeri M, Anwar Y, Wilairatana P, Rauf A, Halawani IF, Alzahrani FM, Khan H.

Brain Res. 2024 Jul 1;1834:148886. doi: 10.1016/j.brainres.2024.148886. Epub 2024 Apr 4.

Potential Alzheimer's disease drug targets identified through microglial biology research

Lepiarz-Raba I, Hidayat T, Hannan AJ, Jawaid A.

Expert Opin Drug Discov. 2024 May;19(5):587-602. doi: 10.1080/17460441.2024.2335210. Epub 2024 Apr 8.

Pharmacological interventions to improve sleep in people with Alzheimer's disease: a meta-analysis of randomized controlled trials

Bedward A, Kaur J, Seedat S, Donohue H, Kow CS, Rasheed MK, Javed A, Hasan SS.

Expert Rev Neurother. 2024 May;24(5):527-539. doi: 10.1080/14737175.2024.2341004. Epub 2024 Apr 10.

Serotonergic dysfunction may mediate the relationship between alcohol consumption and Alzheimer's disease

Pierson SR, Kolling LJ, James TD, Pushpavathi SG, Marcinkiewcz CA.

Pharmacol Res. 2024 May;203:107171. doi: 10.1016/j.phrs.2024.107171. Epub 2024 Apr 9.

Targeting VDAC: A potential therapeutic approach for mitochondrial dysfunction in Alzheimer's disease

Yang Y, Jia X, Yang X, Wang J, Fang Y, Ying X, Zhang M, Wei J, Pan Y.

Brain Res. 2024 Jul 15;1835:148920. doi: 10.1016/j.brainres.2024.148920. Epub 2024 Apr 8.

Innovative approaches to Alzheimer's therapy: Harnessing the power of heterocycles, oxidative stress management, and nanomaterial drug delivery system

Umar M, Rehman Y, Ambreen S, Mumtaz SM, Shaququzzaman M, Alam MM, Ali R.

Ageing Res Rev. 2024 Jun;97:102298. doi: 10.1016/j.arr.2024.102298. Epub 2024 Apr 10.

Recent Advances in Drug Delivery Systems Targeting Insulin Signalling for the Treatment of Alzheimer's Disease

Sachdeva P, Narayanan KB, Sinha JK, Gupta S, Ghosh S, Singh KK, Bhaskar R, Almutary AG, Zothantluanga JH, Kotta KK, Nelson VK, Paiva-Santos AC, Abomughaid MM, Kamal M, Iqbal D, ALHarbi MH, ALMutairi AA, Dewanjee S, Nuli MV, Vippamakula S, Jha SK, Ojha S, Jha NK.

J Alzheimers Dis. 2024;98(4):1169-1179. doi: 10.3233/JAD-231181.

Neuroinflammation of Microglial Regulation in Alzheimer's Disease: Therapeutic Approaches

Chen H, Zeng Y, Wang D, Li Y, Xing J, Zeng Y, Liu Z, Zhou X, Fan H.

Molecules. 2024 Mar 26;29(7):1478. doi: 10.3390/molecules29071478.

Alzheimer's Amyloid Hypothesis and Antibody Therapy: Melting Glaciers?

Høilund-Carlsen PF, Alavi A, Castellani RJ, Neve RL, Perry G, Revheim ME, Barrio JR.

Int J Mol Sci. 2024 Mar 31;25(7):3892. doi: 10.3390/ijms25073892.

Potential Therapeutic Targets to Modulate the Endocannabinoid System in Alzheimer's Disease

Kanwal H, Sangineto M, Ciarnelli M, Castaldo P, Villani R, Romano AD, Serviddio G, Cassano T.

Int J Mol Sci. 2024 Apr 5;25(7):4050. doi: 10.3390/ijms25074050.

Amyloid antibody therapy for early-stage Alzheimer's disease: a critical review of three recent trials

Guiloff AE, Rudge P.

J Neurol. 2024 May;271(5):2914-2916. doi: 10.1007/s00415-024-12361-w. Epub 2024 Apr 13.

A turn for the worse: Aβ β-hairpins in Alzheimer's disease

Ruttenberg SM, Nowick JS.

Bioorg Med Chem. 2024 May 1;105:117715. doi: 10.1016/j.bmc.2024.117715. Epub 2024 Apr 10.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias